← Leaderboards
Michail Sitkovsky
Niaid Extramural Activities
$6,204,774
Attributed
$7,084,614
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$7,084,614 · 5
By mechanism
R01$5,396,340 · 3
U19$1,301,466 · 1
R21$386,808 · 1
Top collaborators
- Daniel G. Remick4 shared
- Akio Ohta1 shared
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Adenosine”
- Chuan He · University Of Chicago$25,386,171
- Raymond C Stevens · University Of Calif-Lawrenc Berkeley Lab$17,634,454
- Joshua A Boyce · Brigham And Women'S Hospital$14,914,539
- Bruce Neil Cronstein · New York University School Of Medicine$14,895,406
- Kazuko Nishikura · University Of Pennsylvania$14,781,272
- Samie R Jaffrey · Weill Medical College Of Cornell Univ$13,696,773
Research focus
AdenosineHypoxiaPreventMediatingCellsImmunosuppressive AgentsT-LymphocyteExtracellularImmune ResponsePathway InteractionsAdenosine A2b ReceptorTissuesGeneticAdenosine A2 ReceptorsImmuneNatural ImmunosuppressionSignal TransductionCancer ImmunotherapyTumorLungReceptorCancer TherapyPharmaceutical PreparationsImmunotherapy
Grant awards (35)
Cancer Immunotherapy by Targeting A2 Adenosine Receptor$214,407
R01 · FY2016 · CA · contact PI
Cancer Immunotherapy by Targeting A2 Adenosine Receptor$214,407
R01 · FY2015 · CA · contact PI
Adenosine and Oxygen Modulate Antimicrobial Defenses$302,762
R01 · FY2014 · GM
Preventing the Hypoxia-Adenosinergic Inhibtion of Anti-HIV Immune Response$257,277
U19 · FY2014 · AI · contact PI
Cancer Immunotherapy by Targeting A2 Adenosine Receptor$207,975
R01 · FY2014 · CA · contact PI
Adenosine and Oxygen Modulate Antimicrobial Defenses$292,165
R01 · FY2013 · GM
Preventing the Hypoxia-Adenosinergic Inhibtion of Anti-HIV Immune Response$251,912
U19 · FY2013 · AI · contact PI
Cancer Immunotherapy by Targeting A2 Adenosine Receptor$201,543
R01 · FY2013 · CA · contact PI
Adenosine and Oxygen Modulate Antimicrobial Defenses$302,747
R01 · FY2012 · GM
Preventing the Hypoxia-Adenosinergic Inhibtion of Anti-HIV Immune Response$226,021
U19 · FY2012 · AI · contact PI
Cancer Immunotherapy by Targeting A2 Adenosine Receptor$214,407
R01 · FY2012 · CA · contact PI
Adenosine and Oxygen Modulate Antimicrobial Defenses$318,440
R01 · FY2011 · GM
Preventing the Hypoxia-Adenosinergic Inhibtion of Anti-HIV Immune Response$281,785
U19 · FY2011 · AI · contact PI
Preventing the Hypoxia-Adenosinergic Inhibtion of Anti-HIV Immune Response$284,471
U19 · FY2010 · AI · contact PI
"Cancer Immunotherapy by Targeting A2 Adenosine Receptor"$216,475
R01 · FY2010 · CA · contact PI
Cancer Immunotherapy by Targeting A2 Adenosine Receptor$543,566
R01 · FY2009 · CA · contact PI
Mechanisms of Tumor Protection for T Cells by Hypoxia$294,007
R01 · FY2009 · CA · contact PI
"Cancer Immunotherapy by Targeting A2 Adenosine Receptor"$216,475
R01 · FY2009 · CA · contact PI
Mechanisms of Tumor Protection for T Cells by Hypoxia$294,007
R01 · FY2008 · CA · contact PI
"Cancer Immunotherapy by Targeting A2 Adenosine Receptor"$216,475
R01 · FY2008 · CA · contact PI
Mechanisms of Tumor Protection for T Cells by Hypoxia$294,007
R01 · FY2007 · CA · contact PI
"Cancer Immunotherapy by Targeting A2 Adenosine Receptor"$216,475
R01 · FY2007 · CA · contact PI
Hyperbaric Oxygenation May Increase Lung Injury$190,558
R21 · FY2007 · AT · contact PI
Mechanisms of Tumor Protection for T Cells by Hypoxia$302,788
R01 · FY2006 · CA · contact PI
"Cancer Immunotherapy by Targeting A2 Adenosine Receptor"$222,940
R01 · FY2006 · CA · contact PI
Hyperbaric Oxygenation May Increase Lung Injury$196,250
R21 · FY2006 · AT · contact PI
Mechanisms of Tumor Protection for T Cells by Hypoxia$310,272
R01 · FY2005 · CA
Purinergic Regulation Of Immune Response$0
Z01 · FY2003 · AI
Purinergic Regulation Of Immune Response$0
Z01 · FY2002 · AI
Molecular And Cellular Mechanisms Of Immunodeficiency Ad$0
Z01 · FY2002 · AI
Purinergic Regulation Of Immune Response$0
Z01 · FY2001 · AI
Molecular/Cellular Mechanisms- Immunodeficiency ADA SCID$0
Z01 · FY2001 · AI
MOLECULAR AND CELLULAR MECHANISMS OF IMMUNODEFICIENCY ADA SCID$0
Z01 · FY2000 · AI
PURINERGIC REGULATION OF IMMUNE RESPONSE$0
Z01 · FY2000 · AI
ANTIGEN SPECIFIC AND ANTIGEN NONSPECIFIC CELLULAR CYTOTOXICITY$0
Z01 · FY2000 · AI